We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fevertree Drinks Plc | FEVR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -8.00 | -1.12% | 709.00 | 16:35:17 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 725.00 | 702.00 | 725.00 | 709.00 | 717.00 |
| Industry Sector |
|---|
| BEVERAGES |
| Top Posts |
|---|
Posted at 27/9/2024 20:29 by philanderer Questor tipLike Terry Smith, we’re keeping hold of this underperformer Investors need to be patient but Fever-Tree’s strategy will come good |
Posted at 06/9/2024 15:00 by martywidget Evening all...Next week: Fevertree, Half Year Results, Thursday 12 September Aarin Chiekrie, equity analyst, Hargreaves Lansdown: Last investors heard, Fevertree LON:FEVR had been scooping up market share across its regions which had helped to increase sales. Innovation across Rum, Vodka and other spirits has helped boost the group’s leading position in the UK, and growth in Europe continues to grow ahead of the broader mixer category. Fevertree’s already said it’s comfortable with full-year expectations, which at the time of the last update in June pointed towards 8% sales growth and underlying cash profit margins of around 15%. Markets will be keeping a close eye on whether these targets are still on track when half-year results are announced next week, with market forecasts currently suggesting this could be a slight stretch. |
Posted at 01/5/2024 17:47 by whittler100 It’s an interesting stock with a pedigree history & has some heavy-weight investors; Fundsmith 7.6% & Lindsell Train 15%. Just my opinion but reasonable mileage to come over the next couple of years.The Deutsche Bank “Buy” of 30/04/24 was an interesting read. |
Posted at 26/3/2024 11:56 by edwardt i guess with the US 12x to the UK market - investors are focused on the TAM there. |
Posted at 04/2/2024 21:24 by apad Based on the long-term graph £10 looks like a base.It doesn't really matter if you are a long-term investor. It is all about maintaining brand value, which doesn't show on the balance sheet. Pears Soap is a wonderfull case study about what happens if you don't work hard at promoting the brand. apad |
Posted at 16/1/2024 14:14 by philanderer Liberum upgrades Fevertree on recovery prospectsLiberum has upgraded premium mixer maker Fevertree (FEVR) as a trough in margins indicates a recovery in this year and next. Analyst Anubhav Malhotra upgraded his recommendation from ‘hold’ to ‘buy’ and increased the target price from £12.00 to £13.00 on the stock, which was trading at £9.98 on Monday. Malhotra said the company’s strategy ‘has been focused on market share gains against a backdrop of significant input cost inflation over the last two years’. Margins have ‘troughed̵ ‘We see scope for a greater recovery in 2024 and 2025 than consensus expects and therefore move to ‘buy’ ‘Despite the [fact] that ‘bad news’ might not be over, the valuation at 17x 12 months forward consensus embedded value/Ebitda and 28x price/earnings – 40-50% below historic average – looks reasonable.’ Mahotra said that for investors ‘wanting to build a position, now is the time considering the low average daily volume of 265,000’. citywire.com |
Posted at 25/1/2023 15:28 by martywidget 26th January 2023 - FY22 Pre-close trading updateMarch 2023 FY22 - Preliminary Results |
Posted at 15/7/2022 11:14 by 123trev It’s ok must be just a coincidence then before your time I guess a couple of my closest friends used to frequent this board and one has a strikingly similar username to yours lol perhaps he will turn up old investors will understand but sorry for the confusion. |
Posted at 16/3/2022 13:36 by km18 Fevertree Drinks plc posted prelims for FY21 this morning. Fever-Tree delivered revenue growth of 23%, growing strongly across all markets and extending its position as a leading global premium mixer brand. Revenues were £311.1m, a new record, with adjusted EBITDA of £63m and diluted EPS of 38.19p. The business has been growing consistently strongly for the past decade and looks set to continue this pattern. FEVR has top notch profitability ratios and a strong balance sheet. Unsurprisingly investors have taken note of the success story, valuation remains stretched with forward PE ratio at 37.9 most expensive in the Beverages market. The business is impressive, but the share is excessively expensive. Monitor for now.......from WealthOracleAM |
Posted at 19/2/2022 00:27 by philanderer Lindsell Train star fund manager Nick Train has used cash from the buyout of Daily Mail and General Trust to top up his holdings in Fever-Tree (FEVR) and Experian (EXPN) after their shares slumped in the New Year growth selloff.The buy-and-hold manager of the Lindsell Train UK Equity fund and Finsbury Growth & Income (FGT) investment trust, who is under some pressure after falling behind the stock market and rivals in 2021, was left with a windfall of nearly £250m of cash after the Rothermere family took the Daily Mail publisher private in December. Train told investors he had ploughed the money across the two portfolios but had beefed up the stakes in tonic maker Fever-Tree and credit data provider Experian. ‘The falls in January have meant that we were able to take advantage and deploy this capital, perhaps more quickly and certainly on better terms than we expected. In particular, we were able to add to our holdings in Experian and Fever-Tree at notably lower prices as the month went on and they are now important positions,’ Train said in his monthly update. citywire.com |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
